论文部分内容阅读
近年来,随着抗生素的大量应用及细菌耐药性的产生,临床上重症支气管、肺部感染率明显增加,尤其是医院获得性感染的机率增加更为突出,这就对抗生素提出更高、更新的要求。头孢三代抗生素应用于临床为重症支气管、肺部感染的治疗,尤其是医院内感染提出了较好的疗效,临床上应用包括头孢一、二代抗生素难以控制的感染得到良好的治疗。本文报告了应用头孢咪诺钠(美士灵)治疗重症支气管、肺部感染20例,这些病历都是在应用头孢一、二代抗生素治疗无效时应用美士灵治疗使感染得以控
In recent years, with the large-scale application of antibiotics and the emergence of bacterial resistance, clinically severe bronchus and lung infection rates increased significantly, especially the increased probability of hospital-acquired infection is more prominent, which put forward higher antibiotics, Updated requirements. Three generations of cephalosporins antibiotics used in clinical treatment of severe bronchial and pulmonary infections, especially in hospital infections put forward a good effect, including clinical application of cephalosporin first and second generation of antibiotics is difficult to control the infection is well treated. This paper reports the application of cefminox sodium (Meishin) treatment of severe bronchial and pulmonary infections in 20 cases, these medical records are in the application of cephalosporin first and second generation of antibiotics when the application of metronidazole treatment of infection can be controlled